Diagnostics Innovation Lifestyle and Mind News Preventive Health

Most Americans would take coronavirus vaccine if deemed safe: Reuters/Ipsos poll

Three-quarters of Americans would take a coronavirus vaccine after receiving certain assurances that it was safe, and another 9% would take one as soon as it was available, a Reuters/Ipsos poll released Tuesday showed.

The strong support for a vaccine comes as vocal anti-vaccination protesters joined right-leaning groups to protest shelter-at-home orders imposed by public health officials in the wake of the coronavirus pandemic in the United States.

Development of a safe and effective vaccine is widely believed by public health officials to be key to controlling future outbreaks, but it is not clear how long that process would take – or if a vaccine can even be developed for the virus.

Asked to choose one or more reasons they would feel comfortable taking a new vaccine, about 40% of American adults surveyed in the Reuters/Ipsos study said they would wait until the U.S. Food and Drug Administration approved such a vaccine, and 38% said they would try one after extensive, peer-reviewed clinical trials.

About 38% said they would wait until such a vaccine had already been taken by much of the public and proven safe. A smaller number, about 6%, said they would take a coronavirus vaccine after a friend or family member tried it, and the same number said they would try it if President Donald Trump were to endorse it.

Among those who were willing to be vaccinated against the virus, 89% would do so if it was made in the United States, and 11% said they would take it if it were developed in another country.

“A vaccine would be an important tool, because I don’t think the virus is going to disappear,” said Arthur Reingold, head of epidemiology and biostatistics at the University of California, Berkeley’s School of Public Health.

But he cautioned that people’s willingness to take a vaccine will vary depending on what happens as time progresses.

Read More

Meeta Ramnani
Meeta Ramnani
Meeta develops credible content about various markets based on deep research, opinions from experts and inputs from industry leaders. As the managing editor at Smart Industry News, she assures that every piece of news and article adds to the knowledge of decision makers. An avid bike rider, Meeta, is a postgraduate from Indian Institute of Journalism and New Media (IIJNM) Bangalore, where her specialization was Business Journalism. She carries experience from mainstream print media including The Times Group and Sakal Media Group.
https://smarthealthcarenews.com/